Scientific engagement works best when it’s synchronized with how HCPs are thinking and talking today, not last quarter. That’s why digital sentiment, the tone and direction of expert conversations across professional forums, congress backchannels, preprints,
KEE targeting has evolved. Version 1.0 was spreadsheets of “top names.” Version 2.0 chased digital activity, who posts, where, and how often. KEE Targeting 3.0 goes further: it connects role, behavior, and impact to reveal
Not all influence looks the same. Some experts write guidelines, others steer trial sites, and a growing cohort shapes thinking online. Effective KEE targeting starts with segmentation that goes beyond “who is famous” to “who
Volume isn’t the same as influence. Some Key External Experts shape clinical thinking without posting daily threads or dominating conference panels. They publish pivotal guidelines, lead multi‐center studies, advise payer committees, and move their peers
Identifying and engaging Key Opinion Leaders (KOLs) requires more than just counting followers or publication citations. With rapid digitalization and innovation in the healthcare space, organizations need an “Expert Universe.”
Digital Opinion Leaders (DOLs) have emerged as critical partners for healthcare organizations seeking to amplify scientific insights, foster clinician trust, and accelerate product adoption.
Effective competitive strategy in healthcare hinges on timely, actionable insights. Traditional market research (sales data, prescription volumes, and clinical trial results) often lags behind real-time shifts in clinician and patient perceptions. Social listening fills this
Effective brand management in healthcare requires more than clinical data and sales metrics. Key Opinion Experts (KEEs), clinicians, researchers, and specialized practitioners exert considerable influence over institutional and practitioner adoption decisions. Their real-time perspectives on
In today’s competitive pharmaceutical landscape, a product’s success doesn’t start at launch—it begins long before. The launch strategy sets the stage, initiates critical conversations, and builds the credibility needed to succeed. At the heart of
The way the competitive pharma industry is set up today, success doesn’t start post-launch; it starts well before launch. By the time a product arrives in the market, pharma companies need the right voices, the
Imagine launching a new drug only to realize that it’s struggling in the market due to poor adoption by physicians or simply wrong pricing. Or wasting years doing research, only to be left behind by
Key Opinion Leaders (KOLs) are pivotal in driving scientific innovation, regulatory approvals, and market acceptance. As leading experts in clinical research, KOLs help identify market trends, assess study feasibility, guide recruitment practices, define clinical endpoints,